home / stock / pbyi / pbyi news


PBYI News and Press, Puma Biotechnology Inc From 02/29/20

Stock Information

Company Name: Puma Biotechnology Inc
Stock Symbol: PBYI
Market: NASDAQ
Website: pumabiotechnology.com

Menu

PBYI PBYI Quote PBYI Short PBYI News PBYI Articles PBYI Message Board
Get PBYI Alerts

News, Short Squeeze, Breakout and More Instantly...

PBYI - 3 High-Risk, High-Reward Stocks That Have Massive Upside Potential

There are a lot of promising stocks out there for investors to choose from. However, if you're looking for companies with the most growth potential, the world of small-cap stocks is one of the best places to look. In particular, biotech stocks are very well known for having tremendous upside ...

PBYI - Puma Bio: Sifting Through The Q4 Earnings Report

Puma Biotechnology ( PBYI ) recently publicized their Q4/2019 earnings that revealed a strong beat in both EPS and revenue. Puma reported total revenue for the fourth quarter of 2019 of $62.9M. Total product revenue consisted of license revenue of $4M, royalty revenue of $0.2M and net sale...

PBYI - Will Puma Biotechnology Break Out of Its Rut in 2020?

Aside from an acquisition, earning marketing approval for a drug candidate is the single biggest event that can happen for a development-stage pharmaceutical company. It marks the beginning of the transition to commercial operations and tends to spark a celebration among investors. But sometimes...

PBYI - Global Advances in Breast Cancer Detection Creating $5.13 Billion Opportunity

February 27, 2020 Palm Beach, FL – February 27, 2020  – Globally, breast cancer effects 2.1 million women every year.  In 2018 alone, it was the cause of nearly 627,000 deaths, according to the World Health Organization, accounting for 15% of all cancer deaths ...

PBYI - BYND, ALC among premarket gainers

SELLAS Life Sciences Group (NASDAQ: SLS ) +23%  on positive follow-up phase 1/2 clinical data for Galinpepimut-S in acute myeloid leukemia. More news on: SELLAS Life Sciences Group, Inc., Alcon, Inc., Moderna, Inc., Stocks on the move, , Read more ...

PBYI - Puma Biotechnology Receives U.S. FDA Approval of Supplemental New Drug Application for Neratinib to Treat HER2-Positive Metastatic Breast Cancer

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic H...

PBYI - Puma Biotechnology, Inc. 2019 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Puma Biotechnology, Inc. in conjunction with their 2019 Q4 earnings Read more ...

PBYI - ZS, FSLR among premarket losers

TrueCar (NASDAQ: TRUE )  -29%  after guidance disappoints. More news on: TrueCar, Inc., BlueLinx Holdings Inc., EyePoint Pharmaceuticals, Inc., Stocks on the move, , Read more ...

PBYI - Puma Bio down 10% premarket as Nerlynx sales stall

Puma Biotechnology ( PBYI ) Q4 results : More news on: Puma Biotechnology, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

PBYI - Puma Biotechnology Inc (PBYI) Q4 2019 Earnings Call Transcript

Image source: The Motley Fool. Puma Biotechnology Inc   (NASDAQ: PBYI) Q4 2019 Earnings Call Feb 20, 2020 , 4:30 p.m. ET Operator Continue reading

Previous 10 Next 10